• Mechanical Stress, Cytoskeleton, and Autophagy

  2026-08-23

  The reference study shows that compressive force-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules provide auxiliary support. Its combination of mechanical stimulation, cytoskeletal perturbation, fluorescence imaging, and western blotting offers a framework for distinguishing force sensing from downstream autophagic responses.

• Losartan Workflows for AT1 and Vascular Research

  2026-08-22

  Losartan is a practical angiotensin II receptor antagonist for connecting AT1 signaling with vascular remodeling, blood-pressure phenotypes, and matrix biology. This workflow-oriented guide covers assay setup, formulation, vascular smooth muscle cell proliferation inhibition, and a carefully bounded extension into tumor mechanical microenvironment research.

• Viral vIRD Control of RIPK3 and Inflammation

  2026-08-22

  Liu and colleagues identified vIRD, a cowpox virus and orthopoxvirus protein that recruits the SCF machinery to drive proteasomal degradation of RIPK3, thereby suppressing necroptosis. Viral engineering and mouse genetic experiments showed that vIRD is not simply an immune-evasion factor: its interaction with RIPK3 shapes viral replication, inflammation, mortality, and pathogen–host evolution.

• FCCP as a Systems Probe of Mitochondrial Signaling

  2026-08-21

  FCCP is more than an oxidative phosphorylation uncoupler: it is a strategic perturbation tool for connecting mitochondrial energetics with HIF signaling, metabolic phenotypes, and organelle quality control. This article interprets FCCP through the emerging MARCH5–PEX3 pre-peroxisome axis and offers a translational framework for experimental design, controls, and responsible interpretation.

• HD56 Prodrug Metabolism in Humanized Mice

  2026-08-20

  The reference study shows that humanized-liver mice can resolve species-dependent differences in the activation and disposition of the CES-sensitive prodrug HD56. Its strong in vivo–in vitro correlation, together with transporter, enzyme, microsomal, plasma, and pharmacokinetic experiments, provides a practical framework for improving preclinical translation of ester prodrugs.

• Marein Reverses ABCG2-Mediated Mitoxantrone Resistance

  2026-08-20

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria, as a competitive inhibitor of the ABCG2 drug efflux transporter. By increasing intracellular concentrations of ABCG2 substrates, including Mitoxantrone, marein restored drug sensitivity in resistant cancer-cell models and linked this activity to the conserved F439 residue of ABCG2.

• Iptacopan (LNP023) Workflows for Complement Research

  2026-08-19

  Build more interpretable complement experiments with Iptacopan (LNP023), from alternative-pathway C3bBb inhibition to PNH hemolysis and animal-model studies. This guide combines practical assay design, quantitative controls, troubleshooting, and a risk-modeling insight from a major anticoagulation study.

• SVA 3A and 2B Counter DDX23 Through Apoptosis

  2026-08-19

  The reference study defines a dual host–virus interaction in which DDX23 restricts Senecavirus A (SVA) by promoting 3A degradation through a caspase-2/caspase-6 pathway, while SVA 2B promotes DDX23 loss through a caspase-2/caspase-3 route. By combining DDX23 perturbation, pathway inhibitor experiments, and reverse genetics, the authors identify viral residues that regulate this antagonism and may guide future SVA antiviral or vaccine studies.

• Urolithin A: Reliable Cell Assay Workflows

  2026-08-18

  This scenario-based guide explains how Urolithin A (SKU B7945) can be incorporated into reproducible cell viability, proliferation, and cytotoxicity workflows without confusing mitochondrial effects with cell loss. It covers solvent compatibility, protocol controls, interpretation of hepatic stellate cell data, and practical vendor-selection criteria.

• Latrunculin B: Actin Assay Workflow and Troubleshooting

  2026-08-18

  Latrunculin B enables rapid, reversible actin filament assembly inhibition for time-resolved cytoskeletal experiments. Its transient activity also makes it a useful mechanistic control in endocytosis and viral-entry assays, where exposure conditions and serum effects must be interpreted carefully.

• InstaBlue Protein Stain Solution Protocol

  2026-08-17

  InstaBlue Protein Stain Solution provides rapid Coomassie Brilliant Blue visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and mass spectrometry workflows, but should be validated separately when legacy methanol/acetic acid chemistry or fully quantitative densitometry is required.

• Z-WEHD-FMK for Caspase-1 Pathway Studies

  2026-08-17

  Z-WEHD-FMK enables cell-permeable, irreversible inhibition of inflammatory caspases in pyroptosis, infection, and Golgi-fragmentation workflows. This guide shows how to use it as a mechanistic tool while avoiding the common mistake of interpreting broad caspase blockade as caspase-1-specific proof.

• Oseltamivir acid: Assay Design for Influenza Research

  2026-08-16

  Oseltamivir acid is an influenza neuraminidase inhibitor with value across mechanistic virology, resistance studies, and exploratory oncology research. This article presents an assay-centered framework that separates direct target inhibition, viral spread, compound handling, and species-dependent prodrug interpretation.

• From MAPK10 Mechanism to Protein Assay Strategy

  2026-08-15

  Mechanistic oncology is only as reliable as the protein workflow behind it. This thought-leadership article connects the MAPK10/KRT16/RNF213 axis in NSCLC with practical guidance for preserving phosphorylation, ubiquitination, and native protein interactions during translational sample preparation.

• Making Bone-Repair Signals Translationally Measurable

  2026-08-14

  Bone transport offers a compelling model of angiogenic and osteo-immune coupling, but its translational value depends on molecular measurements that are specific, reproducible, and linked to tissue outcomes. This article examines how RT-qPCR can validate TGF-β1/TGFBR1-associated repair biology and how HotStart™ Universal 2X Green qPCR Master Mix supports rigorous dye-based workflows.

8672 records 8/579 page Previous Next First page 上5页 678910 下5页 Last page